PharmAnalysis Group Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 18

Employees
  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

PharmAnalysis Group General Information

Description

Provider of reimbursement planning for the pharmaceutical, biotechnology, medical device and diagnostics industries. The company's services include reimbursement and economic assessments, qualitative pricing and reimbursement research, coding analysis, marketing support, communications, and program development. It serves pharmaceutical, biotechnology, medical device, and diagnostics industries.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Consulting Services (B2B)
Acquirer
Primary Office
  • 2700 South Quincy Street
  • Suite 230
  • Arlington, VA 22206
  • United States
+1 (703) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmAnalysis Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PharmAnalysis Group‘s full profile, request access.

Request a free trial

PharmAnalysis Group Executive Team (4)

Name Title Board Seat Contact Info
Sandy Robinson Vice President
You’re viewing 1 of 4 executive team members. Get the full list »

PharmAnalysis Group Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial